Pharma & Biotech Global Week in Review 29 July 09 from IP Think Tank

Here is IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet.

Please join the discussion by adding your comments on any of these stories, and please do let us know if you think we’ve missed something important, or if there is a source you think should be monitored.

You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: http://thinkipstrategy.com/subscribe/

 
Highlights this week included:

Tri-Cyclen Lo (Norgestimate, Ethinyl estradiol) – US: Johnson & Johnson, Teva settle patent infringement proceedings – the reverse of a reverse payment? (PatLit) (SmartBrief) (The IP Factor) (GenericsWeb)

US: Are you getting all the patent term you should? Maybe not (Patent Baristas) (Managing Intellectual Property)

 
General

BioPharma royalties European Customs Utah and software – thoughts on les Nouvelles Jun 09 (IP Think Tank)

Drop in R&D funding for HIV vaccine (Intellectual Property Watch)

Balancing act: IP rights vs global public health goals (IP Osgoode)

Doubly fake drugs kill patients, markets – China said to be flooding West Africa with fake medicines bearing ‘Made in India’ labels (Afro-IP)

ECOSOC adopts resolutions on digital divide, HIV/AIDS, but hurdles remain (Intellectual Property Watch)

EU: EPO Enlarged Board of Appeal announces timetable for oral proceedings in case G 2/08 concerning dosage regimen and G 1/07 concerning methods for treatment by surgery (BLOG@IP::JUR)

EU: OHIM says EVIOL confusingly similar to EVION for vitamin preparations: Merck v Gkap Anonymi Etaireia Viomichania Farmakon (Class 46)

EU: BOTOX war update: Allergan chalks up another two victories (Class 46)

India: Is section 3(d) separating wheat from the chaff? (Patent Circle)

India: ‘In transit’ drug seizures and TRIPS: UK decision may help Indian companies (Spicy IP)

India: Public interest litigation to prevent GM seeds in India (IP Osgoode)

Isle of Man: SPCs on the Isle of Man (The SPC Blog)

US: Board decision in Ex Parte Roberts doesn’t make the cut (Patents4Life)

US: Are you getting all the patent term you should? Maybe not (Patent Baristas) (Managing Intellectual Property)

US: Could the ‘new rules’ nightmare finally be over? Tafas v Doll (Patent Docs)

US: For stem cells, it seems that conception is enough: University of Pittsburgh v Hedrick (Patent Docs) (Patents4Life)

US: General Accountability Office report on Bayh-Dole: Leverage to promote commercialisation of federally-funded inventions (PatentBIOtech)

US: AlphaVax seeks review of BPAI decision awarding priority of invention to Novartis in interference between patents related to Alphavirus (Patent Docs)

US: Teva, Taro lobby US legislators on biogenerics (GenericsWeb)

 
Products

Amrix (Cyclobenzaprine) – US: Eurand, Cephalon file patent infringement suit against Anchen over generic Amrix ANDA (Patent Docs)

Avinza (Morphine sulfate) – US: King Pharmaceuticals files patent infringement suit against Sandoz over generic Avinza ANDA (Patent Docs)

Benzimidazole Quinolinones – US: Novartis files suit seeking review and correction of patent term adjustment: Novartis Vaccines and Diagnostics v Doll (Patent Docs)

Ferrlecit (Sodium ferric gluconate) – US: Watson announces license agreement with GeneraMedix for generic version of Ferrlecit (SmartBrief) (GenericsWeb)

Fosamax (Alendronate) – Canada: Federal Court of Appeal upholds validity of generics remedy against innovators’ failed prohibition applications, rejects disgorgement and future losses: Merck Frost Canada v Apotex (Global IP Watch)

Hectorol (Doxercalciferol) – US: Bone Care International files patent infringement suit against Sandoz over generic Hectorol ANDA (Patent Docs)

Humira (Adalimumab) – US: US: JMOL motions filed in Centocor v Abbott (EDTexweblog) (Patently-O)

Nicotinamide ZCF (Nicotinamide, Zinc) – US: River’s Edge files patent infringement suit against Brookstone and JR Nutraceuticals over their nicotinamide zinc oxide, cupric oxide, folic acid tablets product, comparable to plaintiff’s Nicotinamide ZCF (Patent Docs)

Ovide (Malathion) – US: Taro files patent infringement suit against Synerx, Karalex and DPT Laboratories over their manufacture and sale of generic version of Ovide (Patent Docs) (GenericsWeb)

Plavix (Clopidogrel) – US: Bristol-Myers Squibb reaches agreement to settle lawsuits brought against it alleging breach of US securities laws by not disclosing material information about Plavix patent litigation (PatLit)

Soybean Variety XB34D04 – US: Pioneer Hi-Bred files patent infringement suit against Ivan Nelson, Thomas Nelson based on use of saved soybean seed (Patent Docs)

Travatan Z (Travoprost) – US: Alcon files patent infringement suit against Barr over generic Travatan Z ANDA including Para IV certification (Patent Docs)

Tri-Cyclen Lo (Norgestimate, Ethinyl Estradiol) – US: Johnson & Johnson, Teva settle patent infringement proceedings – the reverse of a reverse payment? (PatLit) (SmartBrief) (The IP Factor) (GenericsWeb)

 

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: